Cryopreservation media are specialized formulations designed to protect cells during freezing and thawing processes, ensuring high viability and preserved functionality essential for cell and gene therapy applications. Effective cryopreservation is critical in CGT for long-term storage, transportation, and manufacturing, enabling therapies to maintain potency and safety from development through to clinical use.

Importance of Cryopreservation in CGT

Cryopreservation halts cellular metabolism and molecular activity by cooling cells to temperatures below −130°C, effectively placing them in suspended animation. This process preserves cell integrity over extended periods, allowing flexibility in manufacturing timelines, quality control testing, and global distribution. It is especially vital for sensitive cell types such as hematopoietic stem cells, CAR-T cells, mesenchymal stem cells, and induced pluripotent stem cells (iPSCs).

Key Features of Cryopreservation Media

Cryopreservation media are designed with specific components to optimize cell preservation:

• Cryoprotectants: Most cryopreservation media contain cryoprotective agents like dimethyl sulfoxide (DMSO), which prevent ice crystal formation that can damage cell membranes during freezing. Some formulations are DMSO-free to reduce cytotoxicity, offering alternatives for sensitive cells or clinical applications.
• Optimized Formulations: Commercial cryopreservation media are carefully balanced with cryoprotectants, buffers, and nutrients to minimize osmotic stress and cold shock. This optimization improves post-thaw cell viability and functionality compared to “homebrew” or serum-containing solutions, which can introduce variability and reduce reproducibility.
• Serum-Free and GMP-Grade Options: To meet regulatory standards and reduce variability, many cryopreservation media are available in serum-free and GMP-compliant formats, supporting clinical manufacturing and ensuring consistent quality.

Best Practices in Cryopreservation

Effective cryopreservation requires adherence to best practices to maximize cell viability and functionality:

• Controlled-Rate Freezing: Gradual cooling using controlled-rate freezers helps minimize thermal shock and ice formation, improving cell recovery after thawing. Temperature monitoring and validated freeze curves are essential for reproducibility.
• Pre-Freeze Cell Preparation: Cells should be harvested during the exponential growth phase and washed to remove residual culture medium. Gradual addition of cryoprotectant and pre-chilling the suspension reduce osmotic and thermal stress.
• Storage and Transport: Cryopreserved cells are typically stored in liquid nitrogen vapor phase to maintain stable ultra-low temperatures. Specialized cryoshipping containers with temperature tracking enable safe global transport while preserving cell quality.

Benefits for Cell and Gene Therapy Manufacturing

Cryopreservation media enable scalable and flexible CGT manufacturing by:

• Allowing storage of starting materials and intermediate or final cell products, facilitating batch testing and regulatory compliance.
• Supporting logistics for global distribution and clinical administration, overcoming challenges of fresh cell transport.
• Maintaining cell potency and phenotype post-thaw, critical for therapeutic efficacy.
• Reducing manufacturing risks by enabling inventory management and contingency planning.